Try our Advanced Search for more refined results

Deals Rumor Mill: NPS, Morgan Stanley, Club Med

By Benjamin Horney (January 5, 2015, 6:05 PM EST) -- NPS Pharmaceuticals Inc., a pharmaceutical company known for being a rare-disease specialist, is looking for a buyer, according to a Monday report from the Wall Street Journal. According to the report, Goldman Sachs Group Inc. has been tapped to lead the sale process, which is still in the very early stages. NPS could be valued at more than $4.5 billion in a sale, according to the report. The report noted that Shire PLC has shown interest in buying NPS in the past and could be a prime candidate....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!